- Home
- SWVL vs DYAI Comparison
SWVL vs DYAI Comparison
Compare SWVL & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWVL
- DYAI
- Stock Information
- Founded
- SWVL 2017
- DYAI 1979
- Country
- SWVL United Arab Emirates
- DYAI United States
- Employees
- SWVL N/A
- DYAI N/A
- Industry
- SWVL Business Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SWVL Consumer Discretionary
- DYAI Health Care
- Exchange
- SWVL Nasdaq
- DYAI Nasdaq
- Market Cap
- SWVL 30.3M
- DYAI 30.2M
- IPO Year
- SWVL N/A
- DYAI 2004
- Fundamental
- Price
- SWVL $3.55
- DYAI $1.13
- Analyst Decision
- SWVL
- DYAI Strong Buy
- Analyst Count
- SWVL 0
- DYAI 2
- Target Price
- SWVL N/A
- DYAI $4.50
- AVG Volume (30 Days)
- SWVL 11.9K
- DYAI 106.6K
- Earning Date
- SWVL 09-08-2025
- DYAI 11-10-2025
- Dividend Yield
- SWVL N/A
- DYAI N/A
- EPS Growth
- SWVL N/A
- DYAI N/A
- EPS
- SWVL N/A
- DYAI N/A
- Revenue
- SWVL $19,329,423.00
- DYAI $4,135,078.00
- Revenue This Year
- SWVL N/A
- DYAI $34.23
- Revenue Next Year
- SWVL N/A
- DYAI $19.57
- P/E Ratio
- SWVL N/A
- DYAI N/A
- Revenue Growth
- SWVL N/A
- DYAI 129.20
- 52 Week Low
- SWVL $2.40
- DYAI $0.71
- 52 Week High
- SWVL $7.50
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- SWVL 59.16
- DYAI 52.71
- Support Level
- SWVL $3.04
- DYAI $1.10
- Resistance Level
- SWVL $3.18
- DYAI $1.27
- Average True Range (ATR)
- SWVL 0.22
- DYAI 0.11
- MACD
- SWVL 0.04
- DYAI 0.00
- Stochastic Oscillator
- SWVL 67.58
- DYAI 44.84
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.